• 1
    Creteur J, Sibbald W, Vincent J-L, et al. Hemoglobin solutions – not just red blood cell substitutes. Crit Care Med 2000; 28 (8): 30252034.
  • 2
    Sellards A, Minot G. The injection of hemoglobin in man and its relation to blood destruction with special reference to the anemias. J Med Res 1916; 34: 469494.
  • 3
    Amberson WR, Flexner J, Steggerda FR, et al. On the use of Ringer-Locke solution containing hemoglobin as a substitute for normal blood in animals. J Cell Comp Physiol 1934; 5: 359382.
  • 4
    Amberson WR, Jennings JJ, Rhode CM. Clinical experience with hemoglobin-saline solution. J Appl Physiol 1949; 1: 469489.
  • 5
    Rabiner SF, O'Brien K, Peskin GW, et al. Further studies with stroma-free hemoglobin solution. Ann Surg 1970; 171: 615622.
  • 6
    Savitzky JP, Doczi J, Black J, et al. A clinical trial with stroma-free hemoglobin. Clin Pharmacol Ther 1978; 23: 7380.
  • 7
    Haney CR, Buehler PW, Gulati A. Purification and chemical modifications of hemoglobin on developing hemoglobin based oxygen carriers. Adv Drug Deliv Rev 2000; 40: 153169.
  • 8
    Winslow RM. Blood substitutes. Adva Drug Deliv Rev 2000; 40: 131142.
  • 9
    Palaparthy R, Wang H, Gulati A. Current aspects in pharmacology of modified hemoglobins. Adva Drug Deliv Rev 2000; 40: 185198.
  • 10
    Meisner FG, Kemming GI, Habler OP, et al. Diaspirin crosslinked hemoglobin enables extreme hemodilution beyond the critical hematocrit. Crit Care Med 2001; 29 (4): 829838.
  • 11
    Jahr JS, Nesargi SB, Lewis K, et al. Blood substitutes and oxygen therapeutics: an overview and current status. Am J Ther 2002; 9: 437443.
  • 12
    The future of blood substitutes. American Association of Blood Banks Newsletter, January/February 2002. pp. 21–24.
  • 13
    Sartescji LM, Sagripanti A, Carpi A, et al. Rationale for the development of red-cell substitutes and status of the research. Int Med 2001; 9: 3644.
  • 14
    Stowell CP, Levin J, Spiess BD, et al. Progress in the development of RBC substitutes. Transfusion 2001; 41: 287299.
  • 15
    Spahn DR, Leone BJ, Reves JG, et al. Cardiovascular and coronary physiology of acute isovolemic hemodilution: a review of nonoxygen-carrying and oxygen-carrying solutions. Anesth Analg 1994; 78: 10001021.
  • 16
    Vlahakes GJ, Lee L, Jacobs EE, et al. Hemodynamic effects and oxygen transport properties of a new blood substitute in a model of massive blood replacement. J Thor Cardiovasc Surg 1990; 100: 379388.
  • 17
    Bosman RJ, Minton J, Ju HR, et al. Free polymerized hemoglobin versus hydroxyethyl starch in resuscitation of hypovolemic dogs. Anesth Analg 1992; 75: 811817.
  • 18
    Harringer W, Hodakowski GT, Jacobs EE, et al. Acute effects of massive transfusion of a bovine hemoglobin blood substitute in a canine model of hemorrhagic shock. Eur J Cardio-Thor Surg 1992; 6: 649654.
  • 19
    Standl TG, Horn P, Wilhem C, et al. Bovine hemoglobin is more potent than autologous red blood cells in restoring tissue oxygenation after profound isovolemic hemodilution in dogs. Can J Anaesth 1996; 43 (7): 714723.
  • 20
    Driessen B, Jahr JS, Lurie F, et al. Inadequacy of low-volume resuscitation with hemoglobin-based oxygen carrier hemoglobin glutamer-200 (bovine) in canine hypovolemia. J Vet Pharmacol Ther 2001; 24: 6171.
  • 21
    Driessen B, Jahr JS, Lurie F, et al. Effect of haemoglobin-based oxygen carrier hemoglobin glutamer-200 (bovine) on intestinal perfusion and oxygenation in a canine hypovolaemia model. Br J Anaesth 2001; 86 (5): 683692.
  • 22
    Cheung AT, Jahr JS, Driessen B, et al. The effects of hemoglobin glutamer-200 (bovine) on the microcirculation in a canine hypovolemia model: a noninvasive computer-assisted intravital microscopy study. Anesth Analg 2001; 93: 832838.
  • 23
    Moon PF, Bliss SP, Posner LP, et al. Fetal oxygen content is restored after maternal hemorrhage and fluid replacement with polymerized bovine hemoglobin, but not with hetastarch, in pregnant sheep. Anesth Analg 2001; 93: 142150.
  • 24
    Horn E-P, Standl T, Wilhelm S, et al. Bovine hemoglobin increases skeletal muscle oxygenation during 95% artificial arterial stenosis. Surgery 1997; 121: 411418.
  • 25
    Krieter H, Hagen G, Waschke KF, et al. Isovolemic hemodilution with a bovine hemoglobin-based oxygen carrier: effects on hemodynamics and oxygen transport in comparison with a nonoxygen-carrying volume substitute. J Cardiothor Vasc Anesth 1997; 11 (1): 39.
  • 26
    Powell CC, Schultz SC, Burris DG, et al. Subcutaneous oxygen tension: a useful adjunct in assessment of perfusion status. Crit Care Med 1995; 23: 867873.
  • 27
    Frankel HL, Nguyen HB, Shea-Donohue T, et al. Diaspirin cross-linked hemoglobin is efficacious in gut resuscitation as measured by a GI tract optode. Trauma 1996; 40 (2): 231240.
  • 28
    Nolte D, Steinhauser P, Pickelmann S, et al. Effects of diaspirin-cross-linked hemoglobin (DCLHbTM) on local tissue oxygen tension in striated skin muscle: an efficacy study in the hamster. J Lab Clin Med 1997; 130: 328338.
  • 29
    Kerger H, Tsai A, Saltzman DJ, et al. Fluid resuscitation with O2 vs. non-O2 carriers after 2 h of hemorrhagic shock in conscious hamsters. Am J Physiol 1997; 272: H525H537.
  • 30
    Boltzar A, Steinhauser P, Nolte D. Effects of ultra-purified polymerized bovine hemoglobin on local tissue oxygenation in striated skin muscle – an efficacy study in the hamster. Eur Surg Res 2002; 43: 106113.
  • 31
    Dawidson I, Drukker S, Hedlund B, et al. Deleterious effects of stroma-free hemoglobin used as resuscitative fluid in rats with ischemic intestinal shock. Crit Care Med 1988; 16: 606609.
  • 32
    Chang TM, Varma R. Effect of a single replacement of one of Ringer's lactate, hypertonic saline/dextran, albumin, stroma-free hemoglobin, o-raffinose polyhemoglobin or whole blood on the long term survival of anesthetized rats with lethal hemorrhagic shock after 67% blood loss. Biomat Art Cells Immob Biotech 1992; 20: P503P510.
  • 33
    Kelly N, Rentko VT. Comparative cardiovascular response by Oxyglobin versus packed red blood cells in acute anemia. J Vet Emerg Crit Care 1998; 8 (3): 252.
  • 34
    Walton RS. Polymerized hemoglobin versus hydroxyethyl starch in an experimental model of feline hemorrhagic shock. Proceedings IVECCS, 1996, San Antonio.
  • 35
    Dries DJ Hypotensive resuscitation. Shock 1996; 6 (5): 311316.
  • 36
    Manning JE, Katz LM, Brownstein MR, et al. Bovine hemoglobin-based oxygen carrier (HBOC-201) for resuscitation of uncontrolled, exsanguinating liver injury in swine. Shock 2000; 13 (2): 152159.
  • 37
    McNeil JD, Smith DL, Jenkins DH, et al. Hypotensive resuscitation using a polymerized bovine hemoglobin-based oxygen-carrying solution (HBOC-201) leads to a reversal of anaerobic metabolism. J Trauma 2001; 50: 10631075.
  • 38
    Manley G, Morabito D, Hemphill J, et al. Effect of small-volume resuscitation with hemoglobin substitute HBOC-201 on brain tissue oxygenation following hemorrhagic shock. J Trauma 2000; 48 (1): 195196.
  • 39
    Ditchey RV, Winkler JV, Rhodes CA. Relative lack of coronary blood flow during closed-chest resuscitation in dogs. Circulation 1982; 66: 297302.
  • 40
    Sanders AB, Ogie M, Ewy GA. Coronary perfusion pressure during cardiopulmonary resuscitation. Am J Emerg Med 1985; 3: 1114.
  • 41
    Paradis NA, Rose MI, Gawryl MS. Selective aortic perfusion and oxygenation: an effective adjunct to external chest compression-based cardiopulmonary resuscitation. J Am Coll Card 1994; 23 (2): 497504.
  • 42
    Sanders AB, Kern KB, Ewy GA, et al. The effect of balloon occlusion on the coronary perfusion pressure during cardiopulmonary resuscitation. Clin Res 1983; 31: 829.
  • 43
    Paradis NA. Dose–response relationship between aortic infusions of polymerized bovine hemoglobin and return of circulation in a canine model of ventricular fibrillation and advanced life support. Crit Care Med 1997; 25 (3): 476483.
  • 44
    Manning JE, Katz LM, Pearce B, et al. Selective aortic arch perfusion with hemoglobin-based oxygen carrier-201 for resuscitation from exsanguinating cardiac arrest in swine. Crit Care Med 2001; 29 (11): 20672074.
  • 45
    Furchgott W, Martin P. Blockade of endothelium-dependent vasodilation by hemoglobin: a possible factor in vasospasm associated with hemorrhage. Adv Prostaglandin Thromboxane Leukotriene Res 1985; 15: 499502.
  • 46
    Habler OP, Kleen M, Pape A, et al. Diaspirin-crosslinked hemoglobin reduces mortality of severe hemorrhagic shock in pigs with critical coronary stenosis. Crit Care Med 2000; 28 (6): 18891898.
  • 47
    Habler OP, Messemer KF. Tissue perfusion and oxygenation with blood substitutes. Adva Drug Deliv Rev 2000; 40: 171184.
  • 48
    Caron A, Menu P, Faivre-Fiorina B, et al. Cardiovascular and hemorheologic effects of three modified hemoglobin solutions in hemodiluted rabbits. J Appl Physiol 1999; 86 (2): 541548.
  • 49
    Caron A, Malfatti E, Aguejouf O, et al. Vasoconstrictive response of rat mesenteric arterioles following infusion of cross-linked, polymerized, and conjugated hemoglobin solutions. Art Cell Blood Subs Immob Biotech 2001; 29 (1): 1930.
  • 50
    Muir WW, De Morais HS, Constable PD. The effects of a hemoglobin-based oxygen carrier (HBOC-301) on left ventricular systolic function in anesthetized dogs. Vet Surg 2000; 29: 449455.
  • 51
    Heneka MT, Lšschmann P-A, Osswald H. Polymerized hemoglobin restores cardiovascular and kidney function in endotoxin-induced shock in the rat. J Clin Invest 1997; 99 (1): 4754.
  • 52
    Jia L, Bonaventure J, Stamler J. S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature 1996; 380: 221226.
  • 53
    Intaglietta M, Johnson PC, Winslow RM. Microvascular and tissue oxygenation distribution. Cardiovasc Res 1996; 32: 632643.
  • 54
    Federspiel W, Popel A. A theoretical analysis of the effect of particulate nature of blood on oxygen release in capillaries. Microvasc Res 1986; 32: 164189.
  • 55
    Tsai A. Influence of cell-free Hb on local tissue perfusion and oxygenation in acute anemia after isovolemic hemodilution. Transfusion 2001; 41: 12901298.
  • 56
    Gulati A, Sharma AC, Singh G. Role of endothelin in the cardiovascular effects of diaspirin crosslinked and stroma reduced hemoglobin. Crit Care Med 1996; 24: 137147.
  • 57
    Schultz SC, Grady B, Cole F, et al. A role for endothelin and nitric oxide in the pressor response to diaspirin cross-linked hemoglobin. J Lab Clin Med 1993; 122: 301308.
  • 58
    Cohn SM, et al. Resuscitation of pulmonary contusion: effects of a red blood cell substitute. Crit Care Med 1997; 25: 484491.
  • 59
    Chan DL, Freeman LM, Rozanski EA, et al. Colloid osmotic pressure of parenteral nutrition components and intravenous fluids. J Vet Emerg Crit Care 2001; 11 (4): 269273.
  • 60
    Wolthuis A, Peek D, Scholten R, et al. Effect of the hemoglobin-based oxygen carrier HBOC-201 on laboratory instrumentation: Cobas Integra, Chiron Blood Gas Analyzer 840, Sysmex™ SE-9000 and BCT. Clin Chem Lab Med 1999; 37 (1): 7176.
  • 61
    Jahr JS, Lurie F, Driessen B, et al. The HemoCue®, a point of care B-hemoglobin photometer, measures hemoglobin concentrations accurately when mixed in vitro with canine plasma and three hemoglobin-based oxygen carriers (HBOC). Can J Anesth 2002; 49 (3): 243248.
  • 62
    Lurie F, Jahr JS, Driessen B. The Novel HemoCue plasma/low hemoglobin system accurately measures small concentrations of three different hemoglobin-based oxygen carriers in plasma: hemoglobin-glutamer-200 (bovine) (Oxyglobin®), hemoglobin-glutamer-250 (bovine)(Hemopure¨), and hemoglobin-raffimer (Hemolink™). Anesth Analg 2002; 95: 870873.
  • 63
    Jahr JS, Lurie F, Gosselin R, et al. Effects of hemoglobin glutamer-250 (bovine) (HBOC-201, Hemopure) on coagulation testing. Am J Ther 2002; 9: 431436.
  • 64
    Jahr JS, Lurie F, Driessen B, et al. Validation of oxygen saturation measurements in a canine model of hemoglobin based oxygen carrier (HBOC) infusion. Clin Lab Research 2000; 13 (3): 173178.
  • 65
    Griffiths E, Cortes A, Gilbert N, et al. Haemoglobin-based blood substitutes and sepsis. Lancet 1995; 345: 158160.
  • 66
    Langermans AM, Bleeker WK. Haemoglobin-based blood substitutes and infection. Lancet 1995; 345: 863864.
  • 67
    Alayash AI, Summers AG, Wood F, et al. Effects of glutaraldehyde polymerization on oxygen transport and redox properties of bovine hemoglobin. Arch Biochem Biophys 2001; 391 (2): 225234.
  • 68
    McFaul SJ, Bowman PD, Villa VM, et al. Hemoglobin stimulates mononuclear cells to release interleukin-8 and tumor necrosis factor alpha. Blood 1994; 84: 31753181.
  • 69
    Rabinovici R, Rudolph AS, Vernick J, et al. Lyophilized liposome encapsulated hemoglobin: evaluation of hemodynamic, biochemical, and hematologic responses. Crit Care Med 1994; 22: 480485.
  • 70
    Johnson JL, Moore EE, Offner PJ, et al. Resuscitation with a blood substitute abrogates pathologic postinjury neutrophil cytotoxic function. J Trauma 2001; 50 (3): 449456.
  • 71
    Linberg R, Conover CD, Shum KL, et al. Hemoglobin based oxygen carriers: how much methemoglobin is too much? Art Cell Blood Subs Immob Biotech 1998; 26 (2): 133148.
  • 72
    Lee R, Neya K, Svizzero TA, et al. Limitations of the efficacy of hemoglobin-based oxygen-carrying solutions. J Appl Physiol 1995; 79: 236242.
  • 73
    Gould SA, Moore EE, Hoyt DB, et al. The first randomized trial of human polymerized hemoglobin as a blood substitute in acute trauma and emergency surgery. J Am Coll Surg 1998; 187: 113120.
  • 74
    Carmichael FJL, Ali ACY, Campbell JA, et al. A phase I study of oxidized raffinose cross-linked human hemoglobin. Crit Care Med 2000; 28 (7): 22832292.
  • 75
    Cheng DCH. Safety and efficacy of o-raffinose cross-linked human hemoglobin (Hemolink™) in cardiac surgery. Can J Anesth 2001; 48 (4): S41S48.
  • 76
    Standl T, Burmeister M-A, Horn E-P, et al. Bovine haemoglobin-based oxygen carrier for patients undergoing haemodilution before liver resection. Br J Anaesth 1998; 80 (2): 189194.
  • 77
    Levy JH, Goodnough LT, Greilich P, et al. Polymerized bovine hemoglobin solution as a replacement for allogenic red blood cell transfusion after cardiac surgery: results of a randomized, double-blind trial. J Thor Cardiovasc Surg 2002; 124: 3542.
  • 78
    LaMuraglia GM, O'Hara PJ, Baker WH, et al. The reduction in allogenic transfusion requirement in aortic surgery with a hemoglobin-based solution. J Vasc Surg 2000; 31: 299308.
  • 79
    Sprung J, Kindscher JD, Wahr JA, et al. The use of bovine hemoglobin glutamer-250 (Hemopure®) in surgical patients: results of a multicenter, randomized, single blinded trial. Anesth Analg 2002; 94: 799808.
  • 80
    Kasper S-M, Walter M, Grune F, et al. Effects of a hemoglobin-based oxygen carrier (HBOC-201) on hemodynamics and oxygen transport in patients undergoing preoperative hemodilution for elective abdominal aortic surgery. Anesth Analg 1996; 83: 921927.
  • 81
    Kasper S-M, Grune F, Walter M, et al. The effects of increased doses of bovine hemoglobin on hemodynamics and oxygen transport in patients undergoing preoperative hemodilution for elective abdominal aortic surgery. Anesth Analg 1998; 87: 284291.
  • 82
    Sprung J, Popp H, O'Hara P. The successful use of hemoglobin-based oxygen carrier as a primary blood substitute during abdominal aneurysm repair with large blood loss. Anesth Analg 2001; 92: 14131415.
  • 83
    Mullon J, Giacoppe G, Clagett C, et al. Transfusions of polymerized bovine hemoglobin in a patient with severe autoimmune hemolytic anemia. N Engl J Med 2000; 342 (22): 16381643.
  • 84
    Gannon CJ, Napolitano LM. Severe anemia after gastrointestinal hemorrhage in a Jehovah's Witness: new treatment strategies. Crit Care Med 2002; 30 (8): 18931895.
  • 85
    Hamilton RG, Kelly N, Gawryl MS, et al. Absence of immunopathology with repeated IV administration of bovine Hb-based oxygen carrier in dogs. Transfusion 2001; 41: 219225.
  • 86
    Giger U, Griot-Wenk A, Rosenwieg M, et al. Purified hemoglobin used as a blood substitute in the treatment of parasite-induced anemia in dogs. J Vet Int Med 1991; 5: 140141.
  • 87
    Rentko VA, Wohl J, Murtaugh R, et al. Clinical trial of a hemoglobin based oxygen-carrying (HBOC) fluid in the treatment of anemia in dogs. J Vet Intern Med 1996; 10: 177178.
  • 88
    Rentko VT, Handler SR, Hanson BJ. Influence of oxygen-carrying support on survival in dogs with immune-mediated hemolytic anemia: 143 cases. Proceedings IVECCS, 2002. p. 210.
  • 89
    Grundy SA, Barton C. Influence of drug therapy on survival of dogs with immune-mediated hemolytic anemia: 88 cases (1989–1999). J Am Vet Med Assoc 2001; 218 (4): 543548.
  • 90
    Day TK. Therapeutic challenge: everything but the kitchen zinc. Vet Forum 2000; 17 (1): 4849.
  • 91
    Wall RE, Day TK, Mott J, et al. Oxygen-carrying fluids: clinical application of Oxyglobin® solution. Comp Cont Ed 1999; 21 (8 H, Suppl): 120.
  • 92
    Wall RE. Therapeutic challenge: acute onset of lethargy and anorexia. Vet Forum 1999; 16 (10): 6567.
  • 93
    Day TK, Duffy TC, Kirby R, et al. Tissue perfusion and oxygenation – clinical cases. Comp Cont Ed 2001; 23 (7A): 216.
  • 94
    Rentko V. Practical use of a blood substitute, In: BonaguraJD. ed. Kirk's Current Veterinary Therapy XIII Small Animal Practice. Philadelphia: Blackwell Publishing; 2000. pp. 424426.
  • 95
    Crystal M, Kirby R, Muir WW, et al. Tissue in desperate need of oxygen: roundtable on transfusion triggers. Vet Forum 1999; 16 (4): 5057.
  • 96
    Gaynor J, Ivers S, Macintire D, et al. Fluid therapy: New concepts, new options (Roundtable on results-based management). Vet Forum 2000; 17 (6): 5259.
  • 97
    Jenkins CM, Kirby R, Rudloff E. Comparing the use of polymerized stroma-free hemoglobin (Oxyglobin) and hetastarch during resuscitation of dogs with gastric-dilatation volvulus syndrome. Proceedings IVECCS, Orlando, FL, 2000. p. 788.
  • 98
    Gibson GR, Callan MB, Hoffman V, et al. Use of a hemoglobin-based oxygen-carrying solution in cats: 72 cases (1998–2002). J Am Vet Assoc 2002; 221 (1): 96102.
  • 1
    Kirby R, Rudloff E, Wilson W. Cats are not dogs in critical care, In: BonaguraJD. ed. Kirk's Current Veterinary Therapy XIII Small Animal Practice. Philadelphia: Blackwell Publishing; 2000. pp. 99104.
  • 100
    Crystal MA, Mott J, Van Der Veldt P. Blood loss and no matching donor. Vet Forum 1999; 16 (3): 7273.
  • 101
    Nolte DM, Crovatto A. Cyanosis from acetaminophen toxicosis. Vet Forum 1999; 16 (7): 5557.
  • 102
    Belgrave RL, Hines MT, Keegan R, et al. Effects of a polymerized bovine hemoglobin blood substitute administered to ponies with normovolemic anemia. J Vet Intern Med 2002; 16: 396403.
  • 103
    Maxson AD, Giger U, Sweeney CR, et al. Use of a bovine hemoglobin preparation in the treatment of cyclic ovarian hemorrhage in a miniature horse. J Am Vet Med Assoc 1993; 203 (9): 13081311.
  • 104
    Perkins GA, Fulton RB. Polymerized hemoglobin therapy in a foal with neonatal isoerythrolysis. J Vet Emerg Crit Care 2001; 11 (2): 141146.
  • 105
    Vin R, Bedenice D, Rentko V, et al. The use of ultrapurified bovine hemoglobin solution in the treatment of two cases of presumed red maple toxicosis in a miniature horse and a pony. J Vet Emerg Crit Care 2002; 12 (3): 169175.
  • 106
    Narurkar NS, Thomas JS, Phalen DN. Heinz-body hemolytic anemia associated with ingestion of methylene blue in a river otter. J Am Vet Assoc 2002; 220 (3): 363366.
  • 107
    McEwen M-M, Moon-Massat PF, Butler EC, et al. Polymerized bovine hemoglobin (Oxyglobin solution) administration in two river otters (Lutra canadevsis). Vet Anaesth Analg 2002; 28: 214219.
  • 108
    Abou-Madi N, Garner M, Kollias GV, et al. The use of Oxyglobin in birds: preliminary pharmacokinetics and effects on selected blood parameters and tissues. Proceedings AAZV, AAWV, ARAV, NAZWV Joint Conference, 2001. pp. 7779
  • 109
    Lichtenberger M, Rosenthal K, Brue R, et al. Administration of Oxyglobin and 6% hetastarch after acute blood loss in psittacine birds. Proceedings of the Association of Avian Veterinarians, 2001. p. 15.